Bionano Genomics Inc. (BNGO)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
1. 25
-0.12
-8.7591%
$
16.13M Market Cap
- P/E Ratio
- Div Yield
181,100 Volume
-6.61 Eps
$ 1.37
Previous Close Investors:
Want to track BNGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bionano Genomics Inc. (BNGO) Statistics
Valuation metrics
Market Cap 16.13M
Enterprise value 17.7M
Trailing P/E (ttm) -0.34
Forward P/E -1.12
PEG ratio -0
Price/Sales (ttm) 0.49
Price/Book (mrq) 0.46
Enterprise Value/Revenue 0.59
Enterprise Value/EBITDA -0.79
Overview
Shares outstanding 11.28M
Float 10.3M
Shares short 1.13M
% Held by insiders 0.07%
% Held by institutions 0.1%
Average volume (10 days) 193.73K
Average volume (90 days) 932.32K
Price summary
52-Week low 1
52-Week high 2.23
Beta 1.62
50-Day moving average 1.45
200-Day moving average 1.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:60
Last split Date 27 Jan 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.07%
Operating margin -1.07%
Operational effectiveness
Return on assets -0.68%
Return on equity -0.79%
Income Statement
Revenue (ttm) 28.74M
Revenue per share (ttm) 2.61
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 13.5M
EBITDA -23.37M
Net income to common (ttm) -31.6M
Diluted EPS (ttm) -2.79
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) 14.4M
Total cash per share (mrq) 0.86
Total debt (mrq) 17.01M
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 2.48%
Book value per share (mrq) 2.74
Cash Flow
Cash flow statement -19.3M
Levered free cash flow (LFCF) -5.73M
2026 © Marketlog. All Rights Reserved.
